Molecular and Clinical Risk Factors for Recurrence of Skull Base Chordomas
- 1 September 2013
- journal article
- website
- Published by Oxford University Press (OUP) in Journal of Neuropathology and Experimental Neurology
- Vol. 72 (9), 816-823
- https://doi.org/10.1097/nen.0b013e3182a065d0
Abstract
The official journal of the American Association of Neuropathologists, Inc. Publishes original articles on neuropathology and experimental neuroscience, book reKeywords
This publication has 35 references indexed in Scilit:
- An integrated functional genomics approach identifies the regulatory network directed by brachyury (T) in chordomaThe Journal of Pathology, 2012
- Recurrent Chromosomal Copy Number Alterations in Sporadic ChordomasPLOS ONE, 2011
- The T-box transcription factor Brachyury promotes epithelial-mesenchymal transition in human tumor cellsJCI Insight, 2010
- T (brachyury) gene duplication confers major susceptibility to familial chordomaNature Genetics, 2009
- Target-driven exploratory study of imatinib mesylate in children with solid malignancies by the Innovative Therapies for Children with Cancer (ITCC) European ConsortiumEuropean Journal of Cancer, 2009
- Potential therapeutic targets for chordoma: PI3K/AKT/TSC1/TSC2/mTOR pathwayBritish Journal of Cancer, 2009
- Evaluation of 1p36 markers and clinical outcome in a skull base chordoma studyNeuro-Oncology, 2008
- Frequent deletion of the CDKN2A locus in chordoma: analysis of chromosomal imbalances using array comparative genomic hybridisationBritish Journal of Cancer, 2007
- American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast CancerJournal of Clinical Oncology, 2007
- Chromosome 7 abnormalities are common in chordomasCancer Genetics and Cytogenetics, 2005